Levena Suzhou Biopharma

Levena Biopharma is a specialized biotechnology company and Contract Development and Manufacturing Organization (CDMO) focused on the development of Antibody-Drug Conjugates (ADCs). As a subsidiary of Sorrento Therapeutics, the company provides comprehensive services including site-specific conjugation technology, linker-payload synthesis, and GMP manufacturing of ADC drug substances. Their proprietary platforms, such as K-lock and C-lock, enable the production of homogeneous ADCs with improved therapeutic indexes compared to traditional random conjugation methods. Levena operates state-of-the-art facilities in Suzhou, China, and San Diego, California, supporting global biopharmaceutical partners from early-stage discovery through clinical development. The company is recognized for its integrated approach, managing both the complex chemistry of payloads and the biological requirements of antibody production.